Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005929
Filing Date
2025-04-30
Accepted
2025-04-30 08:12:59
Documents
23
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A mgtx-20250612xdef14a.htm   iXBRL DEF 14A 891352
2 GRAPHIC mgtx-20250612xdef14a_a001.jpg GRAPHIC 7106
3 GRAPHIC mgtx-20250612xdef14a_a002.jpg GRAPHIC 3530
4 GRAPHIC mgtx-20250612xdef14a_a003.jpg GRAPHIC 5683
5 GRAPHIC mgtx-20250612xdef14a_a004.jpg GRAPHIC 7180
6 GRAPHIC mgtx-20250612xdef14a_a011.jpg GRAPHIC 61439
7 GRAPHIC mgtx-20250612xdef14a_a012.jpg GRAPHIC 65087
8 GRAPHIC mgtx-20250612xdef14a_bg001.jpg GRAPHIC 104321
9 GRAPHIC mgtx-20250612xdef14a_bg002.jpg GRAPHIC 112047
  Complete submission text file 0001558370-25-005929.txt   2586916

Data Files

Seq Description Document Type Size
10 EX-101.SCH mgtx-20250612.xsd EX-101.SCH 3794
11 EX-101.LAB mgtx-20250612_lab.xml EX-101.LAB 3688
12 EX-101.PRE mgtx-20250612_pre.xml EX-101.PRE 3928
25 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20250612xdef14a_htm.xml XML 250336
Mailing Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 646-860-7985
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38520 | Film No.: 25891129
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)